Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma.

MLA

Nakahata, Shingo, et al. “Clinical Significance of Soluble CADM1 as a Novel Marker for Adult T-Cell Leukemia/Lymphoma.” Haematologica, vol. 106, no. 2, Feb. 2021, pp. 532–42. EBSCOhost, https://doi.org/10.3324/haematol.2019.234096.

APA

Nakahata, S., Syahrul, C., Nakatake, A., Sakamoto, K., Yoshihama, M., Nishikata, I., Ukai, Y., Matsuura, T., Kameda, T., Shide, K., Kubuki, Y., Hidaka, T., Kitanaka, A., Ito, A., Takemoto, S., Nakano, N., Saito, M., Iwanaga, M., Sagara, Y., … Morishita, K. (2021). Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma. Haematologica, 106(2), 532–542. https://doi.org/10.3324/haematol.2019.234096

Chicago

Nakahata, Shingo, Chilmi Syahrul, Ayako Nakatake, Kuniyo Sakamoto, Maki Yoshihama, Ichiro Nishikata, Yoshinori Ukai, et al. 2021. “Clinical Significance of Soluble CADM1 as a Novel Marker for Adult T-Cell Leukemia/Lymphoma.” Haematologica 106 (2): 532–42. doi:10.3324/haematol.2019.234096.